Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 7.1045 | 90 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 7.18171 | 90 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 6.9451 | 88 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 7.30386 | 90 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 7.50891 | 91 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 6.29636 | 86 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 6.85116 | 89 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 7.06179 | 89 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 6.88015 | 88 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 7.07835 | 89 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 7.2759 | 91 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 7.27832 | 90 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 7.02009 | 89 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 7.08127 | 89 |